Despite Early Promise GLP-1 Disappoints in Parkinson’s ...Middle East

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD. Medscape Medical News

Hence then, the article about despite early promise glp 1 disappoints in parkinson s was published today ( Friday 07/02/2025 - 08:59 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Despite Early Promise GLP-1 Disappoints in Parkinson’s )

Also on site :

• ‘Harry Potter’ Series Star Paapa Essiedu Says He’s Received Death Threats Over Snape Casting: ‘I’ve Been Told, “Quit or I’ll Murder You”’
• Door Cam Catches Healthcare Worker After 7-Hour Shift—Footage Says It All
• Dozens injured after missile strike in Southern Israel